Study identifier:NIS-ONL-FAS-2005/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients (FORUM)
Breast Cancer
N/A
-
-
-
-
Observational
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|